ARVINAS (ARVN) stock: insider trades, news & valuation
Net sellingShare price and insider trades
ARVINAS insider trading at a glance (Oct 9, 2026): in the past 12 months, 1 insider bought $268K and 6 sold $1.4M of ARVN stock on the open market.
Get emailed when insiders cluster-buy stocks like ARVN
Free alerts the day a new cluster buy is filed, plus the Monday report of the week's biggest insider trades.
Free · unsubscribe anytime · not investment advice · see a sample issue
ARVN insider buying and selling by quarter
Open-market purchases (green, above the line) and sales (red, below), by trade date.
| Quarter | Bought | Purchases | Sold | Sales |
|---|---|---|---|---|
| Q4 2026 | — | 0 | — | 0 |
| Q3 2026 | — | 0 | — | 0 |
| Q2 2026 | — | 0 | $518K | 8 |
| Q1 2026 | $268K | 1 | $901K | 14 |
| Q4 2025 | — | 0 | $2K | 1 |
Valuation, profit and volume
Summary
Over the past 12 months, 1 ARVINAS, INC. insider reported open-market purchases totaling $268K, while 6 insiders reported sales totaling $1.4M. 2 of 23 recorded sales were made under pre-scheduled Rule 10b5-1 trading plans, which are usually less informative than discretionary sales.
ARVN earnings: how the stock reacted
Each quarterly results release (SEC 8-K Item 2.02), the trend before it, insider trades in the 30 days before, and the 2-day market reaction. “E” marks releases on the chart above.
| Release | 15 days before | Insiders, 30 days before | Reaction (2 days) | Next 30 days |
|---|---|---|---|---|
| Aug 4, 2026 | +0.6% | None | +4.2%S&P +1.6% | +11.8% |
| May 12, 2026 | -7.5% | Sold $432K | +2.2%S&P +0.4% | -23.2% |
| Feb 24, 2026 | -8.8% | Sold $363K | +8.1%S&P +1.6% | -24.1% |
| Nov 5, 2025 | -1.9% | None | +4.8%S&P -0.7% | +27.9% |
| Aug 6, 2025 | +1.2% | None | -18.0%S&P +0.7% | +25.5% |
| May 1, 2025 | +26.9% | None | -19.8%S&P +2.2% | -6.7% |
| Feb 11, 2025 | +4.6% | None | -5.4%S&P -0.2% | -53.0% |
| Oct 30, 2024 | +7.1% | None | -3.9%S&P -2.3% | +1.1% |
Most companies bar insiders from trading in the weeks before results, so pre-earnings purchases are rare and often made by directors or under pre-set plans. Past reactions don't predict future ones.
Insider transactions
Open-market purchases and sales.
| Filed | Insider | Type | Shares | Price | Value | Since | Score |
|---|---|---|---|---|---|---|---|
| Jun 24SEC | Andrew SaikCFO | Sell Plan | 5,696187,432 held (−3%) | $8.16 | $46K | -6.4% | — |
| Jun 18SEC | Angela M CacaceChief Scientific Officer | Sell Plan | 2,576180,390 held (−1%) | $7.60 | $20K | +0.5% | — |
| May 22SEC | Randy TeelCEO, President | Sell | 2,209285,009 held (−1%) | $9.04 | $20K | -15.5% | — |
| May 13SEC | Andrew SaikCFO | Sell | 11,139193,128 held (−5%) | $9.94 | $111K | -23.1% | — |
| May 13SEC | Noah BerkowitzChief Medical Officer | Sell | 11,108191,395 held (−5%) | $9.94 | $110K | -23.1% | — |
| May 13SEC | Angela M CacaceChief Scientific Officer | Sell | 9,657182,966 held (−5%) | $9.94 | $96K | -23.1% | — |
| May 13SEC | Randy TeelCEO, President | Sell | 9,657287,218 held (−3%) | $9.94 | $96K | -23.1% | — |
| May 13SEC | David K LoomisVp, Chief Accounting Officer | Sell | 1,91940,193 held (−5%) | $9.94 | $19K | -23.1% | — |
| Mar 19SEC | Noah BerkowitzChief Medical Officer | Sell | 6,435202,503 held (−3%) | $11.10 | $71K | -31.2% | — |
| Mar 9SEC | Briggs MorrisonDirector | Buy | 20,00096,021 held (+26%) | $13.40 | $268K | -43.0% | — |
| Mar 2SEC | John G HoustonDirector | Sell | 18,8221,133,970 held (−2%) | $13.24 | $249K | -42.3% | — |
| Mar 2SEC | John G HoustonDirector | Sell | 11,7871,122,183 held (−1%) | $13.14 | $155K | -41.9% | — |
| Mar 2SEC | John G HoustonDirector | Sell | 4,6881,152,792 held (−0%) | $13.24 | $62K | -42.3% | — |
| Feb 25SEC | Randy TeelCEO, President | Sell | 3,748149,696 held (−2%) | $12.16 | $46K | -37.2% | — |
| Feb 25SEC | Angela M CacaceChief Scientific Officer | Sell | 2,571147,623 held (−2%) | $12.16 | $31K | -37.2% | — |
| Feb 25SEC | David K LoomisChief Accounting Officer | Sell | 1,10829,692 held (−4%) | $12.16 | $13K | -37.2% | — |
| Feb 25SEC | Angela M CacaceChief Scientific Officer | Sell | 1,038150,194 held (−1%) | $12.16 | $13K | -37.2% | — |
| Feb 25SEC | Randy TeelCEO, President | Sell | 1,038153,444 held (−1%) | $12.16 | $13K | -37.2% | — |
| Feb 18SEC | Noah BerkowitzChief Medical Officer | Sell | 5,685163,938 held (−3%) | $11.89 | $68K | -35.7% | — |
| Feb 18SEC | Andrew SaikCFO | Sell | 5,134159,267 held (−3%) | $11.89 | $61K | -35.7% | — |
| Feb 18SEC | Angela M CacaceChief Scientific Officer | Sell | 4,592151,232 held (−3%) | $11.89 | $55K | -35.7% | — |
| Feb 18SEC | Randy TeelCEO, President | Sell | 4,403154,482 held (−3%) | $11.89 | $52K | -35.7% | — |
| Feb 18SEC | David K LoomisChief Accounting Officer | Sell | 1,01630,800 held (−3%) | $11.89 | $12K | -35.7% | — |
| Nov 7SEC | David K LoomisChief Accounting Officer | Sell | 23031,697 held (−1%) | $9.89 | $2K | -22.8% | — |
Insiders at ARVINAS, INC.
| Insider | Bought | Sold | Last filing | Score |
|---|---|---|---|---|
| Briggs MorrisonDirector | $268K | — | Mar 9, 2026 | — |
| John G HoustonDirector | — | $466K | Mar 2, 2026 | — |
| Noah BerkowitzChief Medical Officer | — | $249K | May 13, 2026 | — |
| Randy TeelCEO, President | — | $227K | May 22, 2026 | — |
| Andrew SaikCFO | — | $218K | Jun 24, 2026 | — |
| Angela M CacaceChief Scientific Officer | — | $214K | Jun 18, 2026 | — |
| David K LoomisVp, Chief Accounting Officer | — | $47K | May 13, 2026 | — |
ARVN stock: common questions
Are ARVINAS, INC. insiders buying ARVN stock?
In the past 12 months, 1 insiders reported open-market purchases of ARVN worth $268K. The latest was Director Briggs Morrison bought $268K of ARVN at $13.40 — first open-market purchase in our records; raises the stake by 26%.
Are ARVINAS, INC. insiders selling ARVN stock?
6 insiders reported sales worth $1.4M over the same period.
Where does this data come from?
Every transaction comes from Form 4 filings that insiders must submit to the SEC within two business days of a trade. We pull them from SEC EDGAR every night.
What is ARVN's 52-week range?
Over the past year ARVN has traded between $6.98 and $13.83. It last closed at $7.64 on Oct 9, 2026.